Vikas Lifecare Limited (VIKASLIFE) AI Stock Analysis

• Market Cap: ₹3.90B
• Dividend Yield: N/A
• Average Volume (3M): 850.96K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.39
• Revenue Growth: 9.42%
• EPS Growth: -12220.00%
• Country: IN
• Employees: 36
• Sector: Healthcare
• Sector Strength: 45
• Industry: Chemicals - Specialty
• EPS (TTM): -0.02
• Shares Outstanding: 1,857,668,600
• 10 Day Avg. Volume: 448,294
• 30 Day Avg. Volume: 850,962
• PEG Ratio: 0.26
• Price to Book (P/B): 0.87
• Price to Sales (P/S): 0.96
• P/FCF Ratio: -1.95
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 44 Neutral
• Price Target: ₹2.00 ▼(-4.76% Downside)

The overall stock score of 44 reflects significant financial and technical challenges. The company's declining profitability, increased debt, and negative cash flows are major concerns. Technical indicators point to bearish momentum, and the valuation is unattractive due to a negative P/E ratio and no dividend yield. These factors collectively suggest a cautious approach to this stock.

Vikas Lifecare Limited Business Overview & Revenue Model

Company Description

Vikas Lifecare Limited engages in the trading of various chemicals compounds, polymers, PVC resins, plastic granules, and products related to plastic industry in India. It operates through Real Estate, Trading- Polymers, Trading-Cashew Nuts, and Manufacturing divisions. The company is also involved in the real estate business; and the manufacture of recycled material for automotive, packaging, sheathing, and textile industries. In addition, it manufactures and sells polymer compounds, which include PE, PVC, V blend SOE, and polypropylene compounds, as well as thermo plastic rubber; deals in FMCG, cashew nuts, aluminum foils, and processed food products. Vikas Lifecare Limited also exports its products. The company was formerly known as Vikas Multicorp Limited and changed its name to Vikas Lifecare Limited in April 2021. Vikas Lifecare Limited was incorporated in 1995 and is based in New Delhi, India.

How the Company Makes Money

Vikas Lifecare Limited generates revenue primarily through the sale of its chemical products, including agrochemicals and polymer materials, to various industries such as agriculture, construction, and manufacturing. The company’s revenue model is built on both direct sales to customers and distribution agreements with key partners, expanding its reach in domestic and international markets. Additionally, Vikas Lifecare may benefit from strategic partnerships that allow for enhanced distribution capabilities and access to new customer segments, further contributing to its earnings. The company also explores opportunities in exporting its products, which can lead to increased revenue streams in foreign markets.

Vikas Lifecare Limited Financial Statement Overview

Summary

Vikas Lifecare Limited is facing financial challenges with declining profitability, increased debt, and negative cash flows. Despite maintaining a strong equity base, significant improvement in operational performance is required to enhance financial health.

Income Statement

Vikas Lifecare Limited has shown volatile revenue growth with a notable decline in profitability. The gross profit margin is low, indicating cost pressures, and the net profit margin has deteriorated into negative territory, reflecting operational challenges. The EBIT and EBITDA margins have also weakened, contributing to financial instability.

Balance Sheet

The balance sheet demonstrates a moderate debt-to-equity ratio, suggesting a balanced approach to leveraging, though the debt has increased significantly over the year. The return on equity is negative due to net losses, but the equity ratio remains strong, indicating solid capital structure despite profitability challenges.

Cash Flow

Cash flow analysis reveals negative free cash flow growth and poor operating cash flow, indicating liquidity challenges. The operating cash flow to net income ratio is negative, reflecting operational inefficiencies. The company needs to improve cash generation to support its operations.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	4.80B	4.80B	4.46B	4.76B	3.01B	749.95M
Gross Profit	86.62M	38.79M	262.04M	243.20M	101.59M	112.35M
EBITDA	-16.41M	43.56M	240.93M	-160.98M	427.24M	43.39M
Net Income	-112.78M	-106.14M	140.29M	-152.99M	286.99M	-35.02M
Balance Sheet
Total Assets	0.00	7.29B	5.55B	4.55B	3.21B	1.49B
Cash, Cash Equivalents and Short-Term Investments	57.31M	431.74M	159.36M	113.13M	77.05M	1.88M
Total Debt	0.00	767.00M	344.90M	304.07M	230.77M	417.57M
Total Liabilities	-5.33B	1.96B	762.67M	1.21B	1.21B	822.82M
Stockholders Equity	5.33B	5.32B	4.77B	3.31B	1.99B	666.70M
Cash Flow
Free Cash Flow	0.00	-2.36B	-577.20M	-1.28B	-281.03M	-91.52M
Operating Cash Flow	0.00	-2.24B	-417.48M	-1.10B	-148.84M	-76.82M
Investing Cash Flow	0.00	1.03B	-906.01M	-366.38M	-385.14M	119.21M
Financing Cash Flow	0.00	1.12B	1.37B	1.51B	590.87M	-42.69M

Vikas Lifecare Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 2.10
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:VIKASLIFE, the sentiment is Negative. The current price of 2.1 is below the 20-day moving average (MA) of 2.17, below the 50-day MA of 2.22, and below the 200-day MA of 2.77, indicating a bearish trend. The MACD of -0.04 indicates Positive momentum. The RSI at 35.94 is Neutral, neither overbought nor oversold. The STOCH value of 44.44 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:VIKASLIFE.

Vikas Lifecare Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ALBERTDAVD	59 Neutral	₹4.61B	73.18	―	0.62%	-9.14%	-91.11%
MEDICAMEQ	59 Neutral	₹4.98B	49.73	―	0.28%	-9.90%	33.18%
LYKALABS	58 Neutral	₹3.46B	45.09	―	―	19.40%	1286.88%
ZIMLAB	56 Neutral	₹3.32B	35.97	―	―	-3.36%	-47.58%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
VIKASLIFE	44 Neutral	₹3.90B	-34.65	―	―	9.42%	-12220.00%
NECLIFE	43 Neutral	₹3.11B	30.02	―	―	-3.41%	-3028.44%

Vikas Lifecare Limited Corporate Events

Vikas Lifecare Ensures Regulatory Compliance with SEBI Certificate Submission

Vikas Lifecare Limited has submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, detailing the securities dematerialized and rematerialized for the quarter ending September 30, 2025. This compliance ensures transparency and adherence to regulatory requirements, potentially reinforcing investor confidence and maintaining the company’s standing in the stock exchanges.

Vikas Lifecare Limited Conducts 30th Annual General Meeting Virtually

Vikas Lifecare Limited held its 30th Annual General Meeting on September 29, 2025, through video conferencing, in compliance with regulatory requirements. The meeting included participation from 234 members and key company directors and executives. The proceedings of the meeting were conducted as per the agenda outlined in the notice dated September 6, 2025. The results of the e-voting and remote e-voting will be shared separately, indicating a structured approach to shareholder engagement.

Vikas Lifecare Dispatches AGM Notice and Annual Report

Vikas Lifecare Limited has announced the completion of dispatching the notice and annual report for its 30th Annual General Meeting (AGM) to its members. This step is part of their compliance with regulatory requirements, ensuring transparency and communication with stakeholders. The notice has been published in prominent newspapers, indicating the company’s commitment to maintaining open channels of communication with its investors and the broader market.

Vikas Lifecare Completes Dispatch of AGM Notice and Annual Report

Vikas Lifecare Limited announced the completion of dispatching the notice and annual report for its 30th Annual General Meeting (AGM) to its members. The notice, which includes e-voting information and book closure details, was published in the Financial Express and Jansatta newspapers. This step is part of the company’s compliance with regulatory requirements and ensures that shareholders are informed and can participate in the AGM, reflecting the company’s commitment to transparency and stakeholder engagement.

Vikas Lifecare Limited Publishes Q2 2025 Financial Results

Vikas Lifecare Limited announced the publication of its un-audited financial results for the quarter ending June 30, 2025. These results were advertised in both English and Hindi newspapers, complying with SEBI’s disclosure regulations. This announcement is significant as it reflects the company’s commitment to transparency and regulatory compliance, potentially impacting investor confidence and market perception.